About ERIX
EiRx Therapeutics is a specialist provider of pre-clinical therapeutics to the pharmaceutical industry. Our unique scientific expertise and knowledge in the field of Apoptosis provide a sound base to discover and develop new medicines that will safely and selectively repair this natural process in disease. The potential benefits from these new medicines are enormous, since as many as 70% of all human disease have some defect in the control of Apoptosis.
Apoptosis - the biological process that determines whether cells in our bodies live or die...
http://www.eirx.com/index.html

Purchased some of these on the strength of the PROGRESS UPDATE looks promising.
http://moneyam.uk-wire.com/cgi-bin/articles/200603200701130254A.html

ERX interview with John Pool
http://www.wallstreetreporter.com/interview.php?id=18589&player=real
Latest News
CANCER COLLABORATION WITH BIOMERIEUX SA
http://moneyam.uk-wire.com/cgi-bin/articles/200607120700230534G.html
Biomerieux Web Site
http://www.biomerieux.com/servlet/srt/bio/portail/home
ABOUT ERX Focus Of The Month
http://www.billamag.net/focus-document-text.asp?FocusTextID=1
ERX pdf filehttp://www.eirx.com/eirx_heading_images/Yokohama2005.pdf
19/09/2006 A 50% reduction in breast tumour volume size seen with Eirx lead molecule in animal studies
http://moneyam.uk-wire.com/cgi-bin/articles/200609190700171175J.html

Past and present collaborative partners include:

* bioMieux SA
* Almac Diagnostics Ltd
* Merck & Co, Ltd
* Biofocus plc
* MGI Pharmaceuticals, Inc
* OSI Pharmaceuticals, Inc
* Sareum plc
* Regen Therapeutics plc
* SR Pharma plc

significant news coming

Wake me up when the bid price gets to 1p please!

laurie
I thought you would still be awake after GOO yesterday and today.

dont think we can go wrong with this one

news is def next week

2pm?

what time?

Driver comatosed from the hangover instead!

news at 5pm

POST OF THE DAY!!!!

Luckypicker - 8 Dec'06 - 13:51 - 14594 of 14599


"John K Pool"
13/11/2006 17:14
To

cc

Subject
Re: Shareholder Question





We are looking at producing an analysts note currently, We are not
considering going back to the market, if at all, without some very
significant news
John
----- Original Message -----
From:
To: "John K Pool"
Sent: Monday, November 13, 2006 5:10 PM
Subject: Re: Shareholder Question


> John,
>
> Yes I understand this, but my concern is if we dont get some cash soon ERX
> will run out of cash and turn to the market, which I really am hopeing
> this
> will not be the case. I am hopeing the milestone payments will fund us for
> a number of years.
>
> As you know I commented on the marketing, we have changed broker but no
> broker update, I have noted some PI's have asked Seymore pierce why there
> is no broker note, and they say there is none, why not???, this I believe
> is putting many potential investors off.
>
> I look forward to receiving the annual report
>
> Kind regards

THIS IS THE BIT I LIKE

We are not considering going back to the market, if at all, without some very
significant news

POST OF THE DAY!!!!

PH is still posting on our thread, so he hasn't sold yet.

THIS IS THE BIT I LIKE IN THE ABOVE EMAIL

"We are not considering going back to the market, if at all, without some very
significant news"

ph
Have a nice weekend.

you too...

xxx ;-) both cheeks

should be a good week by all counts

will let you know Friday :)

PH, didnt Henry Ford make cars as long as they were black.

MOST INCONVIENIENT IF THEY ANNOUNCE ON FRIDAY, BEEN INVITED TO A CHRISTMAS DO.. STARTS AT MID-DAY ;-(

Note:


we have news on one of our patents... YYYIIIIIIIIIIPEEEEEEEEEEEEE

7 SURVIVIN in my patents list
Inventor: HAYES IAN (IE); COTTER TOM (IE); (+5) Applicant: EIRX THERAPEUTICS LTD (IE); HAYES IAN (IE); (+6)
EC: C07K14/47A1A; C07K14/47A33 IPC: C07K14/47; A61K38/00; C07K14/435 (+2)
Publication info: WO03091384 - 2003-11-06


read the link

Lilly Highlights Two Collaboration Drugs in Its Pipeline Update
PR Newswire (press release), NY - 22 hours ago
- Plans Broad Phase 2 Cancer Trials for Survivin ASO to Begin Late in 2006 and 2007 - CARLSBAD, Calif., Dec. 11 /PRNewswire-FirstCall ...

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-11-2006/0004488564&EDATE=


Look at patent list for Eirx re: SURVIVIN patent number 7

http://v3.espacenet.com/results?sf=a&FIRST=1&CY=gb&LG=en&DB=EPODOC&TI=&AB=&PN=&AP=&PR=&PD=&PA=eirx&IN=&EC=&IC=&=&=&=&=&=